NGM Biopharmaceuticals' Series D Round

NGM Biopharmaceuticals raised a round of funding on March 23, 2015.

NGM Biopharmaceuticals is a drug discovery company committed to the identification and development of transformational biologics for diabetes, obesity and other cardio-metabolic diseases. The Company …

Articles about NGM Biopharmaceuticals' Series D Round: